Table 4.

DenTiUS Deep Plaque clinical indices were obtained for test group B on day 4 (phase 1: receiving the placebo mouthwash) and day 8 (phase 2: receiving the cymenol mouthwash)

DenTiUS Deep Plaque clinical indices	Test group B		p-value
	Phase 1_Day 4 (Mean % ± S.D.)	Phase 2_Day 8 (Mean % ± S.D.)
Visible plaque area (absolute)	46.57 ± 18.92	65.12 ± 16.37	< 0.001
Visible plaque area (relative)	40.53 ± 18.48	59.24 ± 16.90	< 0.001
Total plaque area	62.75 ± 16.85	74.52 ± 13.55	< 0.001
Visible plaque area growth (absolute)	0.49 ± 0.20	0.34 ± 0.08	< 0.001
Visible plaque area growth (relative)	0.43 ± 0.19	0.31 ± 0.08	0.001
Total plaque area growth	0.67 ± 0.18	0.39 ± 0.07	< 0.001

Total plaque: visible plaque + non-visible plaque

SD, standard deviation